Bank Of New York Mellon Corp Assertio Holdings, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$3.54 - $6.66 $1.03 Million - $1.94 Million	290,832 New	290,832 $1.85 Billion
Q4 2022 Feb 14, 2023	BUY	$2.11 - $4.3 $308,425 - $628,543	146,173 New	146,173 $628,000
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $80,469 - $151,116	37,779 Added 115.67%	70,440 $160,000
Q2 2022 Aug 15, 2022	BUY	$1.88 - $3.42 $41,873 - $76,173	22,273 Added 214.41%	32,661 $96,000
Q2 2021 Aug 11, 2021	BUY	$1.48 - $2.88 $15,374 - $29,917	10,388 New	10,388 $16,000

114

37.2M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $58.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.